查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1806125

生医材料市场类型、分类、最终用户和应用—2025-2030 年全球预测

Biomaterials Market by Type, Classification, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年生医材料市场价值将达到499.4亿美元，2025年成长至560.7亿美元，复合年增长率为12.52%，到2030年将达到1013.7亿美元。

主要市场统计数据
基准年2024年 499.4亿美元
预计2025年 560.7亿美元
预测年份 2030 1013.7亿美元
复合年增长率（%） 12.52%

全面介绍生医材料的现状、基础技术以及影响产业的新兴研究前沿

生医材料已成为现代医疗保健的重要基石，推动了组织工程、药物传输和医疗设备创新领域的突破性进展。近年来，聚合物化学、陶瓷复合材料和金属合金领域的进展不断融合，拓展了植入和再生疗法的功能。本介绍将为理解生医材料在改善患者预后以及促进材料科学家、临床医生和製造专业人员之间的跨学科合作方面的关键作用奠定基础。

下一代材料、先进製造技术和协作创新模式推动生医材料发展的革命性变化

在新一代材料和新型製造技术的推动下，生医材料领域正经历快速变革时期。积层製造技术的进步使得复杂植入几何形状的快速原型製作成为可能，同时确保了可重复的品质标准。同时，奈米技术的突破正在促进表面改性，从而增强细胞黏附并促进癒合反应。

评估2025年美国新关税对生医材料市场供应链、成本结构与竞争的累积影响

2025年美国新关税的实施将重塑生医材料供应链，影响关键原料的成本和可得性。从主要製造地进口的陶瓷以及特殊金属合金可能面临更高的关税负担，从而导致下游设备製造商的生产成本上升。为此，企业正在评估替代筹资策略，例如近岸外包和双重采购，以减轻贸易波动的影响。

根据材料类型、分类、最终用户和各种应用领域对生医材料市场进行深入分析，以推动策略重点

对生医材料市场细分的分析揭示了与材料类型、功能分类、使用者群体和应用专业化相关的明确机会领域。按材料类型划分，氧化铝、生物玻璃、羟基磷灰石和氧化锆等陶瓷仍然是硬组织植入的主流，而金属基板继续支撑承重人工关节。从聚己内酯到聚乳酸-乙醇酸再到聚乙烯醇，各种合成聚合物为支架设计和药物传输基质提供了多样化的选择。

战略区域洞察重点关注美洲、中东和非洲以及亚太地区生医材料系统的成长动态和市场驱动力

区域动态对于理解生医材料产业的发展至关重要。在美洲，强大的基础设施和大量的研发投入打造了一个能够快速进行产品开发和临床试验的生态系统。北美的监管途径以结构化的核准流程为特色，为创新者提供了清晰的蓝图；而拉丁美洲市场则因医疗保健管道的扩大和改革倡议提供了新的机会。

来自主要企业的竞争考察，重点介绍领先生医材料供应商的竞争策略、创新管道和合作伙伴关係

生医材料领域的主要企业透过整合创新管道和策略联盟实现差异化。领先的医疗设备製造商以其广泛的全球影响力而闻名，他们利用专有的生物活性涂层和先进的聚合物配方来增强其产品性能。同时，特种化学品公司则利用其在满足严格生物相容性要求的高纯度材料方面的专业知识，进军临床市场。

为产业领导者提供切实可行的建议，以利用新兴趋势、优化供应链并透过策略性倡议巩固市场地位

产业领导者应优先投资生物活性材料和可回收材料，以解决尚未满足的需求，并利用与研究机构的伙伴关係来加速转化研究。采用模组化产品开发方法，企业可以先单独检验组件，然后再整合到综合治疗平台中，从而加快产品上市时间并降低技术风险。

强大的调查方法，强调全面的资料收集、多源三角测量以及严格的定性和定量分析，以确保可靠性

本分析采用稳健的调查方法，将全面的二手资料研究与针对性的一手资料访谈和资料检验结合。材料创新和市场发展的可靠见解来自已发表的科学文献、监管备案文件和专利资料库。资讯来源，我们也访问了材料科学家、生物医学工程师以及供应链和临床机构的高阶主管决策者，进一步充实了这些资料。

总结性见解综合了关键发现，突显了市场机会，并强化了生医材料相关人员的策略重点

研究结果强调了技术创新、不断变化的法规和全球贸易动态之间的动态相互作用，这些相互作用正在塑造生医材料产业：变革性製造方法和协作创新生态系统正在重新定义性能基准，而新的关税制度则需要积极的供应链重组。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 用于组织再生的3D列印生物分解性支架的开发
  • 采用生医材料减少医院内感染
  • 用于癌症标靶治疗的水凝胶递送系统的创新
  • 响应生理刺激的智慧生医材料的进展
  • 创伤护理的新兴永续海洋衍生几丁聚醣生医材料
  • 藻类衍生聚合物作为医疗设备涂层的环保替代品的成长
  • 将人工智慧融入个人化医疗的下一代生医材料设计中
  • 使用导电聚合物的可植入感测器的生物可吸收电子装置的进展

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章生医材料市场（按类型）

  • 陶瓷
    • 氧化铝
    • 生物玻璃
    • 羟基磷灰石
    • 氧化锆
  • 金属
  • 自然的
  • 合成聚合物
    • PCL（聚己内酯​​）
    • PGA（Polyglycolic）
    • PLA（聚乳酸）
    • PLGA（聚乳酸-乙醇酸共聚物）
    • 聚乙烯（PE）
    • 聚丙烯（PP）
    • 聚氨酯（PU）
    • 聚乙烯醇（PVA）

第九章生医材料市场（依类别）

  • 生物活性材料
  • 生物相容性材料
  • 惰性材料

第 10 章生医材料市场（按最终用户）

  • 生技公司
  • 医院
  • 研究所
  • 专科诊所

第 11 章生医材料市场（按应用）

  • 心血管系统
    • 导管导引线
    • 植入式心臟去心房颤动
    • 起搏器
    • 感应器
    • 支架
    • 血管移植
  • 牙科
    • 骨移植和骨替代物
    • 人工植牙
    • 牙膜
    • 组织再生材料
  • 眼科
  • 整形外科
    • 生物可吸收组织固定产品
    • 关节重建生医材料
    • 生物性骨材
    • 脊椎生医材料
    • 关节内粘稠补充疗法
  • 泌尿道
  • 伤口癒合
    • 防沾黏屏障
    • 骨折癒合装置
    • 内部组织密封胶
    • 皮肤替代品
    • 手术止血钳

第 12 章：美洲生医材料市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：欧洲、中东和非洲的生医材料市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

第十四章：亚太生医材料市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Aroa Biosurgery Limited
    • BASF SE
    • Berkeley Advanced Biomaterials Inc.
    • Bezwada Biomedical, LLC
    • Carpenter Technology Corporation
    • Celanese Corporation
    • CoorsTek, Inc.
    • Corbion NV
    • Covestro AG
    • Dentsply Sirona Inc.
    • DSM-Firmenich AG
    • Evonik Industries AG
    • Exactech, Inc.
    • Heraeus Holding GmbH
    • Invibio Limited
    • Medtronic plc
    • Modern Meadow, Inc.
    • MycoWorks, Inc.
    • Noble Biomaterials, Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • TissueForm, Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-434CCDA04CCF

The Biomaterials Market was valued at USD 49.94 billion in 2024 and is projected to grow to USD 56.07 billion in 2025, with a CAGR of 12.52%, reaching USD 101.37 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 49.94 billion
Estimated Year [2025] USD 56.07 billion
Forecast Year [2030] USD 101.37 billion
CAGR (%) 12.52%

Comprehensive Introduction Uncovering the Current Biomaterials Landscape, Core Technology Foundations, and Emerging Research Frontiers Shaping the Industry

Biomaterials have emerged as a pivotal cornerstone in modern healthcare, enabling breakthroughs across tissue engineering, drug delivery, and medical device innovation. In recent years, advances in polymer chemistry, ceramic composites, and metallic alloys have converged to broaden the functional capabilities of implants and regenerative therapies. This introduction provides a foundation for understanding the critical role of biomaterials in enhancing patient outcomes and driving cross-disciplinary collaboration between material scientists, clinicians, and manufacturing specialists.

Emerging research is redefining traditional boundaries, with bioactive ceramics and composite scaffolds integrating biological cues that mimic native tissue microenvironments. Meanwhile, novel metallic frameworks are being engineered to reduce inflammatory responses and improve long-term biocompatibility. In parallel, synthetic polymers are evolving to balance mechanical strength with controlled biodegradation profiles, enabling precision in tissue regeneration protocols.

The interplay between clinical need and material innovation is accelerating the development of personalized solutions, from patient-specific implants to tailored drug delivery platforms. Through understanding both foundational science and applied engineering advances, stakeholders can chart strategic roadmaps that anticipate future demands while mitigating risks inherent in novel product introductions. As we transition into this report, you will gain insights into transformative shifts, trade impacts, segmentation dynamics, and regional nuances shaping the biomaterials landscape.

Revolutionary Transformative Shifts in Biomaterials Development Fueled by Next-Generation Materials, Advanced Manufacturing Techniques, and Collaborative Innovation Models

The biomaterials sector is undergoing a period of rapid transformation driven by next-generation materials and novel manufacturing techniques. Advances in additive manufacturing now enable rapid prototyping of complex implant geometries while ensuring repeatable quality standards. Simultaneously, breakthroughs in nanotechnology are facilitating surface modifications that enhance cellular adhesion and promote accelerated healing responses.

Collaborative innovation models are redefining how academic institutions, start-ups, and established medical device manufacturers co-develop new solutions. By integrating data from real-world evidence platforms and leveraging artificial intelligence algorithms, research teams can optimize material compositions for specific clinical applications more efficiently than ever before. This convergence of digital and materials science is influencing regulatory frameworks, prompting agencies to adopt flexible pathways for validating combination products.

Moreover, sustainability considerations are gaining prominence, prompting industry leaders to explore bio-derived polymers and recyclable composites. The drive toward circular economies is reinforcing investments in biodegradable scaffolds and eco-friendly sourcing practices. Together, these shifts signal a paradigm in which innovation is not only measured by functional performance but also by environmental stewardship and collaborative agility.

Assessing the Cumulative Consequences of New United States Tariffs in 2025 on Supply Chains, Cost Structures, and Competitive Positioning within the Biomaterials Market

The introduction of new United States tariffs in 2025 is poised to reshape the biomaterials supply chain, affecting the cost and availability of critical raw inputs. Ceramics imported from key manufacturing hubs, alongside specialized metallic alloys, may experience increased duty burdens that translate into higher production costs for downstream device manufacturers. In response, companies are evaluating alternative sourcing strategies, including near-shoring and dual-sourcing, to mitigate exposure to trade volatility.

At the same time, synthetic polymers such as PCL and PLA, often produced in regions targeted by the tariffs, could see lead-time fluctuations and margin contractions. This will encourage strategic inventory management and potential consolidation of supplier portfolios. Emerging markets in Europe and Asia Pacific are already positioning themselves as alternative production centers, investing in capacity expansion to capture redirected demand flows.

Despite these challenges, the industry continues to innovate through cost-optimization programs and by exploring tariff classification strategies that align with evolving trade regulations. Companies that proactively engage with customs authorities and diversify their supplier base will be better equipped to absorb short-term shocks and maintain competitive pricing for medical device end users.

Insightful Analysis of Biomaterials Market Segmentation Based on Material Type, Classification, End Users, and Diverse Application Domains Driving Strategic Focus

Analysis of biomaterials market segmentation reveals distinct areas of opportunity tied to material type, functional classification, user groups, and application specialties. Within material type, ceramics such as alumina, bioglass, hydroxyapatite, and zirconia remain pivotal for hard-tissue implants, while metallic substrates continue to underpin load-bearing joint replacements. Natural polymers complement these classes by offering biocompatibility advantages, and synthetic polymers-ranging from polycaprolactone through polylactic-co-glycolic acid to polyvinyl alcohol-provide versatile options for scaffold design and drug delivery matrices.

When considering functional classification, bioactive materials lead in regenerative therapies by actively interacting with biological environments to stimulate tissue growth. Biocompatible materials offer inert scaffolding solutions for long-term implant stability, and bioinert variants provide durable interfaces for devices where tissue response must be minimized. This classification framework guides material selection across diverse biomedical use cases.

End-user segmentation segments the market among biotechnology companies pursuing R&D breakthroughs, hospitals implementing clinical solutions, research laboratories pioneering novel protocols, and specialty clinics delivering targeted therapeutic interventions. Application domains further refine strategic focus areas, with cardiovascular devices-spanning guidewires to vascular grafts-dental innovations from bone graft substitutes to tissue regeneration materials, orthopedic implants including joint replacements and orthobiologics, urinary device technologies, and wound healing systems such as adhesion barriers and surgical hemostats driving specific growth trajectories.

Strategic Regional Insights Unveiling Growth Dynamics and Market Drivers across the Americas, Europe Middle East and Africa, and Asia Pacific Biomaterials Ecosystems

Regional dynamics are central to understanding the biomaterials industry's evolution. In the Americas, robust infrastructure and significant R&D investments create an ecosystem conducive to rapid product development and clinical trials. North American regulatory pathways, characterized by structured approval processes, foster a clear roadmap for innovators, while Latin American markets provide emerging opportunities driven by expanding healthcare access and reform initiatives.

Across Europe, the Middle East, and Africa, diversity in regulatory standards and economic maturity presents both complexity and opportunity. Western Europe's established medical device directives underpin high-value transactions, whereas emerging markets in Eastern Europe and the Gulf region are growing through targeted public-private partnerships and infrastructure enhancements. Africa's nascent healthcare systems are incrementally adopting biomaterial-based interventions, driven by international funding and local capacity building.

The Asia Pacific region stands out for its rapid adoption of advanced healthcare technologies and cost-competitive manufacturing capabilities. Countries in East and Southeast Asia are expanding production hubs for both ceramics and polymers, while regulatory authorities in the region are streamlining approval pathways to attract global investment. Together, these regional ecosystems define the contours of global value chains and strategic market positioning.

Key Company Insights Highlighting Competitive Strategies, Innovation Pipelines, and Collaborative Partnerships Among Leading Biomaterials Providers

Leading companies in the biomaterials sector are differentiating through integrated innovation pipelines and strategic collaborations. Major medical device players, known for extensive global footprints, are augmenting their offerings with proprietary bioactive coatings and advanced polymer formulations. Simultaneously, specialty chemical manufacturers are expanding into clinical markets, leveraging expertise in high-purity materials to meet stringent biocompatibility requirements.

Partnerships between academic institutions and commercial enterprises are accelerating technology transfer, enabling start-ups to scale novel scaffold designs from benchtop validation to regulatory submission. These alliances often involve joint venturing for pilot manufacturing sites and co-development agreements that align intellectual property strategies with market entry timelines. Moreover, several established firms are undertaking targeted acquisitions to fill gaps in regenerative medicine portfolios and reinforce competitive barriers.

Investment trends indicate a growing focus on scalable manufacturing processes, lean supply chains, and digital quality management systems. Companies that optimize their global networks to balance cost efficiency with regulatory compliance will maintain an edge. In parallel, engagement with key opinion leaders and participation in international standards committees reinforce credibility and facilitate market acceptance of next-generation biomaterial solutions.

Actionable Recommendations for Industry Leaders to Capitalize on Emerging Trends, Optimize Supply Chains, and Strengthen Market Position through Strategic Initiatives

Industry leaders should prioritize investment in bioactive and regenerative materials that address unmet clinical needs, leveraging partnerships with research institutions to accelerate translational research. By adopting a modular approach to product development, organizations can validate components individually before integrating them into comprehensive therapy platforms, reducing time to market and mitigating technical risk.

Optimizing supply chains is equally critical. Companies should evaluate dual-sourcing strategies for key raw materials, while exploring near-shoring options to reduce exposure to trade disruptions and shorten lead times. Implementing advanced analytics across procurement and logistics operations will enable real-time visibility, supporting proactive decision-making in response to tariff changes or supplier constraints.

To strengthen market positioning, leadership teams must engage regulatory bodies early in the development lifecycle, seeking alignment on clinical trial design and material characterization requirements. Additionally, pursuing sustainability initiatives-such as recyclable packaging and bio-derived polymer research-will resonate with stakeholder expectations and regulatory trends. Finally, fostering cross-disciplinary talent development programs ensures that internal teams possess the expertise needed to navigate emerging technologies and shifting market dynamics.

Robust Research Methodology Emphasizing Comprehensive Data Collection, Multisource Triangulation, and Rigorous Qualitative and Quantitative Analyses Ensuring Reliability

This analysis leverages a robust research methodology combining comprehensive secondary research with targeted primary interviews and data validation. Publicly available scientific literature, regulatory filings, and patent databases provided foundational insights into material innovations and market developments. These sources were augmented by interviews with material scientists, biomedical engineers, and executive-level decision-makers across supply chain and clinical organizations.

Quantitative data on production volumes, trade flows, and patent filings were triangulated to validate emerging trends, while qualitative feedback from industry stakeholders informed strategic assessments. A rigorous segmentation framework was developed to capture the nuances of material type, functional classification, end-user categories, and application areas.

Throughout the research process, cross-verification mechanisms ensured data integrity, including consistency checks against multiple independent sources and alignment with regional regulatory standards. Competitive benchmarking and scenario analysis were employed to stress-test potential market disruptions, such as tariff impacts and supply chain constraints. This systematic approach underpins the reliability and actionable nature of the insights presented.

Conclusive Insights Synthesizing Key Findings, Highlighting Market Opportunities, and Reinforcing Strategic Priorities for Biomaterials Stakeholders

The findings presented underscore the dynamic interplay of technological innovation, regulatory evolution, and global trade dynamics shaping the biomaterials sector. Transformative manufacturing approaches and collaborative innovation ecosystems are redefining performance benchmarks, while emerging tariff regimes necessitate proactive supply network realignment.

Segmentation insights reveal that targeted investment in bioactive and specialty polymer domains, coupled with strategic engagement of key end-user channels, will unlock high-value opportunities. Regional variations in regulatory complexity and manufacturing capacity highlight the importance of bespoke market entry strategies and localized partnerships.

By integrating these strategic imperatives with agile planning and sustained R&D commitment, companies can position themselves to lead in an environment characterized by rapid scientific advancement and shifting geopolitical landscapes. The path forward requires a balance of innovation, operational resilience, and strategic foresight to drive sustained growth and deliver transformative patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Development of 3D-printed biodegradable scaffolds for tissue regeneration
  • 5.2. Adoption of antimicrobial biomaterials to reduce hospital acquired infections
  • 5.3. Innovations in hydrogel based delivery systems for targeted cancer therapies
  • 5.4. Advancements in smart biomaterials that respond to physiological stimuli
  • 5.5. Emergence of sustainable marine derived chitosan biomaterials in wound care
  • 5.6. Growth of algae derived polymers as ecofriendly alternatives in medical device coatings
  • 5.7. Integration of artificial intelligence in design of next generation biomaterials for personalized medicine
  • 5.8. Advances in bioresorbable electronics using conductive polymers for implantable sensors

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Biomaterials Market, by Type

  • 8.1. Introduction
  • 8.2. Ceramics
    • 8.2.1. Alumina
    • 8.2.2. Bioglass
    • 8.2.3. Hydroxyapatite
    • 8.2.4. Zirconia
  • 8.3. Metallic
  • 8.4. Natural
  • 8.5. Synthetic Polymers
    • 8.5.1. PCL (Polycaprolactone)
    • 8.5.2. PGA (Polyglycolic acid)
    • 8.5.3. PLA (Polylactic acid)
    • 8.5.4. PLGA (Polylactic-co-glycolic acid)
    • 8.5.5. Polyethylene (PE)
    • 8.5.6. Polypropylene (PP)
    • 8.5.7. Polyurethane (PU)
    • 8.5.8. Polyvinyl alcohol (PVA)

9. Biomaterials Market, by Classification

  • 9.1. Introduction
  • 9.2. Bioactive Materials
  • 9.3. Biocompatible Materials
  • 9.4. Bioinert Materials

10. Biomaterials Market, by End User

  • 10.1. Introduction
  • 10.2. Biotechnology Companies
  • 10.3. Hospitals
  • 10.4. Research Laboratories
  • 10.5. Specialty Clinics

11. Biomaterials Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiovascular
    • 11.2.1. Guidewires
    • 11.2.2. Implantable Cardiac Defibrillators
    • 11.2.3. Pacemakers
    • 11.2.4. Sensors
    • 11.2.5. Stents
    • 11.2.6. Vascular Grafts
  • 11.3. Dental
    • 11.3.1. Bone Grafts & Substitutes
    • 11.3.2. Dental Implants
    • 11.3.3. Dental Membranes
    • 11.3.4. Tissue Regeneration Materials
  • 11.4. Ophthalmology
  • 11.5. Orthopedic
    • 11.5.1. Bioresorbable Tissue Fixation Products
    • 11.5.2. Joint Replacement biomaterials
    • 11.5.3. Orthobiologics
    • 11.5.4. Spine Biomaterials
    • 11.5.5. Viscosupplementation
  • 11.6. Urinary
  • 11.7. Wound Healing
    • 11.7.1. Adhesion Barrier
    • 11.7.2. Fracture Healing Device
    • 11.7.3. Internal Tissue Sealant
    • 11.7.4. Skin Substitutes
    • 11.7.5. Surgical Hemostats

12. Americas Biomaterials Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Biomaterials Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Biomaterials Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Aroa Biosurgery Limited
    • 15.3.2. BASF SE
    • 15.3.3. Berkeley Advanced Biomaterials Inc.
    • 15.3.4. Bezwada Biomedical, LLC
    • 15.3.5. Carpenter Technology Corporation
    • 15.3.6. Celanese Corporation
    • 15.3.7. CoorsTek, Inc.
    • 15.3.8. Corbion N.V.
    • 15.3.9. Covestro AG
    • 15.3.10. Dentsply Sirona Inc.
    • 15.3.11. DSM-Firmenich AG
    • 15.3.12. Evonik Industries AG
    • 15.3.13. Exactech, Inc.
    • 15.3.14. Heraeus Holding GmbH
    • 15.3.15. Invibio Limited
    • 15.3.16. Medtronic plc
    • 15.3.17. Modern Meadow, Inc.
    • 15.3.18. MycoWorks, Inc.
    • 15.3.19. Noble Biomaterials, Inc.
    • 15.3.20. Smith & Nephew plc
    • 15.3.21. Stryker Corporation
    • 15.3.22. TissueForm, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. BIOMATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. BIOMATERIALS MARKET: RESEARCHAI
  • FIGURE 24. BIOMATERIALS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. BIOMATERIALS MARKET: RESEARCHCONTACTS
  • FIGURE 26. BIOMATERIALS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BIOMATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOMATERIALS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOMATERIALS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOMATERIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOMATERIALS MARKET SIZE, BY ALUMINA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOGLASS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOMATERIALS MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOMATERIALS MARKET SIZE, BY ZIRCONIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOMATERIALS MARKET SIZE, BY METALLIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOMATERIALS MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOMATERIALS MARKET SIZE, BY PCL (POLYCAPROLACTONE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOMATERIALS MARKET SIZE, BY PGA (POLYGLYCOLIC ACID), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOMATERIALS MARKET SIZE, BY PLA (POLYLACTIC ACID), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOMATERIALS MARKET SIZE, BY PLGA (POLYLACTIC-CO-GLYCOLIC ACID), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYURETHANE (PU), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOMATERIALS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOACTIVE MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOCOMPATIBLE MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOINERT MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOMATERIALS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOMATERIALS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOMATERIALS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOMATERIALS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOMATERIALS MARKET SIZE, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOMATERIALS MARKET SIZE, BY PACEMAKERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOMATERIALS MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOMATERIALS MARKET SIZE, BY STENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOMATERIALS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOMATERIALS MARKET SIZE, BY BONE GRAFTS & SUBSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL MEMBRANES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOMATERIALS MARKET SIZE, BY TISSUE REGENERATION MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOMATERIALS MARKET SIZE, BY BIORESORBABLE TISSUE FIXATION PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOMATERIALS MARKET SIZE, BY JOINT REPLACEMENT BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOMATERIALS MARKET SIZE, BY SPINE BIOMATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOMATERIALS MARKET SIZE, BY VISCOSUPPLEMENTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOMATERIALS MARKET SIZE, BY URINARY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOMATERIALS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOMATERIALS MARKET SIZE, BY FRACTURE HEALING DEVICE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOMATERIALS MARKET SIZE, BY INTERNAL TISSUE SEALANT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOMATERIALS MARKET SIZE, BY SKIN SUBSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOMATERIALS MARKET SIZE, BY SURGICAL HEMOSTATS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES BIOMATERIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 179. CANADA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. CANADA BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. CANADA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. CANADA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. CANADA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 184. CANADA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 185. CANADA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 186. CANADA BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 199. MEXICO BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. MEXICO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. MEXICO BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. MEXICO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 204. MEXICO BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 205. MEXICO BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 206. MEXICO BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 207. MEXICO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 208. MEXICO BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 209. MEXICO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 210. MEXICO BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 219. BRAZIL BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. BRAZIL BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. BRAZIL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. BRAZIL BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. BRAZIL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 224. BRAZIL BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 225. BRAZIL BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 226. BRAZIL BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 227. BRAZIL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 228. BRAZIL BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 229. BRAZIL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 230. BRAZIL BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 231. ARGENTINA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ARGENTINA BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. ARGENTINA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 234. ARGENTINA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 239. ARGENTINA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. ARGENTINA BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. ARGENTINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ARGENTINA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. ARGENTINA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 244. ARGENTINA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 245. ARGENTINA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 246. ARGENTINA BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 247. ARGENTINA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 248. ARGENTINA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 249. ARGENTINA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 250. ARGENTINA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 293. GERMANY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GERMANY BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. GERMANY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 296. GERMANY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 297. GERMANY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 298. GERMANY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 300. GERMANY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 301. GERMANY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. GERMANY BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 303. GERMANY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. GERMANY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 305. GERMANY BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 306. GERMANY BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 307. GERMANY BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 308. GERMANY BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 309. GERMANY BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 310. GERMANY BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 311. GERMANY BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 312. GERMANY BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 313. FRANCE BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. FRANCE BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 315. FRANCE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 316. FRANCE BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 317. FRANCE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 318. FRANCE BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 319. FRANCE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 320. FRANCE BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 321. FRANCE BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. FRANCE BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 323. FRANCE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. FRANCE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. FRANCE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 326. FRANCE BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 327. FRANCE BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 328. FRANCE BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 329. FRANCE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 330. FRANCE BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 331. FRANCE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 332. FRANCE BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 333. RUSSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. RUSSIA BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 335. RUSSIA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 336. RUSSIA BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 337. RUSSIA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 338. RUSSIA BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 339. RUSSIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 340. RUSSIA BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 341. RUSSIA BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. RUSSIA BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 343. RUSSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 344. RUSSIA BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 345. RUSSIA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 346. RUSSIA BIOMATERIALS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
  • TABLE 347. RUSSIA BIOMATERIALS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 348. RUSSIA BIOMATERIALS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
  • TABLE 349. RUSSIA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 350. RUSSIA BIOMATERIALS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
  • TABLE 351. RUSSIA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
  • TABLE 352. RUSSIA BIOMATERIALS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
  • TABLE 353. ITALY BIOMATERIALS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. ITALY BIOMATERIALS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 355. ITALY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 356. ITALY BIOMATERIALS MARKET SIZE, BY CERAMICS, 2025-2030 (USD MILLION)
  • TABLE 357. ITALY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 358. ITALY BIOMATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, 2025-2030 (USD MILLION)
  • TABLE 359. ITALY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2018-2024 (USD MILLION)
  • TABLE 360. ITALY BIOMATERIALS MARKET SIZE, BY CLASSIFICATION, 2025-2030 (USD MILLION)
  • TABLE 361. ITALY BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 362. ITALY BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 363. ITALY BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 364. ITALY BIOMATERIALS MARKET SIZE, BY AP